Ectopic production of human placental lactogen by human breast tumors
β Scribed by Nandini A. Sheth; Jayant N. Suraiya; Anil R. Sheth; Kamal J. Ranadive; D. J. Jussawalla
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- English
- Weight
- 524 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Serum samples from 72 patients with established carcinoma of the breast were investigated for ectopic presence of hPL. Further, the relationship of ectopically-secreted hPL and hCG-P in breast cancer was investigated. Ten of 72 patients examined had detectable hPL and 12 had detectable hCG-P, at 1-2 ng/ml serum sensitivity of the assay. The presence of hPL in serum of breast cancer patients was found to be independent of that of hCG-P. Sera of 13 patients with cystic mastitis, five with fibroadenoma, two with acute inflamation of breast, 20 normal women (non-pregnant) and 20 normal men did not show any detectable serum hPL or hCG-P at the above mentioned sensitivity of the assay. Since these hormones were not detectable in normal men, normal nonpregnant women, and in patients having other pathological conditions of breast, the possible use of them as markers in cancer is expected.
π SIMILAR VOLUMES
## Abstract The effect of exogenous administration of human placental lactogen (HPL) on 7,12βdimethylbenz(a)anthracene (DMBA)βinduced mammary tumors was studied in female SpragueβDawley rats. Twice daily injections of 1 or 2 mg HPL for 20 days showed marked stimulation of appearance and growth of m
We have recently reported that about 30% of breast tumors produce prostate specific antigen (PSA). We examined here, 99 primary ovarian cancer tumors and found relatively low levels of PSA in only three tumors. One patient with metastatic ovarian cancer from a primary breast tumor, produced relative